Assessment of treatment efficacy in HBV infection and disease

This publication has 23 references indexed in Scilit:

• A new strategy for studyingin vitro the drug susceptibility of clinical isolates of human hepatitis B virus
  Hepatology, 2004
• Peginterferon Alfa-2a Alone, Lamivudine Alone, and the Two in Combination in Patients with HBeAg-Negative Chronic Hepatitis B
  New England Journal of Medicine, 2004
• Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy1 ☆
  Gastroenterology, 2004
• Efficacy of Tenofovir Disoproxil Fumarate in Antiretroviral Therapy–Naive and –Experienced Patients Coinfected with HIV‐1 and Hepatitis B Virus
  The Journal of Infectious Diseases, 2004
• In vitro antiviral susceptibility of full-length clinical hepatitis B virus isolates cloned with a novel expression vector
  Antiviral Research, 2004
• Treatment of Chronic Hepatitis B in the Human Immunodeficiency Virus-Infected Patient: Present and Future
  Clinical Infectious Diseases, 2003
• Reconstitution of Hepatitis B Virus (HBV)–Specific T Cell Responses with Treatment of Human Immunodeficiency Virus/HBV Coinfection
  The Journal of Infectious Diseases, 2003
• Monitoring Drug Resistance in Chronic Hepatitis B Virus (HBV)-Infected Patients during Lamivudine Therapy: Evaluation of Performance of INNO-LiPA HBV DR Assay
  Journal of Clinical Microbiology, 2002
• Factors associated with hepatitis B virus DNA breakthrough in patients receiving prolonged lamivudine therapy
  Hepatology, 2001
• Dual Efficacy of Lamivudine Treatment in Human Immunodeficiency Virus/Hepatitis B Virus–Coinfected Persons in a Randomized, Controlled Study (CAESAR)
  The Journal of Infectious Diseases, 1999